PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-27

Date Title Company
27-Sep-2024 DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update Nyxoah SA.
27-Sep-2024 Ensysce Biosciences Receives Notice from Nasdaq AccessWire
27-Sep-2024 FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz) Formycon AG
27-Sep-2024 POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP™ Newswire
27-Sep-2024 POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM) AccessWire
27-Sep-2024 Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Sanofi
27-Sep-2024 During European Myeloma Day, MPE highlights the importance of improving access to clinical trials Myeloma Patients Europe
27-Sep-2024 CQDM and Epitopea Fund the Development and Validation of CryptoMapTM, a Platform Enabling the Development of RNA-based Immunotherapies Epitopea
27-Sep-2024 LEO Pharma Presents Late-Breaking Results from the Phase 2a Mechanism of Action Trial of Temtokibart and Dupilumab in Moderate-to-Severe Atopic Dermatitis at the 2024 EADV Annual Meeting LEO Pharma A/S
27-Sep-2024 Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion Corporation and Aitia
27-Sep-2024 Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies Bayer AG
27-Sep-2024 OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease OMEICOS
27-Sep-2024 DeSci Labs launches novelty scores for scientific manuscripts DeSci Labs
27-Sep-2024 Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster Orion
27-Sep-2024 Inflammatory Bowel Disease Treatment Market to Hit USD 38.2 Billion in 2032 Global Market Insights, Inc.
27-Sep-2024 PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases PolTREG S.A.
27-Sep-2024 SOLARIO study meets its primary endpoints - Bone substitute with local antibiotics enables reduced systemic antibiotic treatment SOLARIO
27-Sep-2024 Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) Pharming Group N.V.
27-Sep-2024 Sorevna Introduces Revolutionary All-Natural Skin Cream for Tough Calluses and Dry Skin AccessWire
27-Sep-2024 MasterWord and UNESCO Join Forces to Preserve and Digitize Mayan Languages for Future Generations AccessWire